Bank of America Reiterates Buy on NextCure, Lowers Price Target from $92 to $89; Sees Data Presented At SITC As 'Incrementally Positive'

Bank of America reiterates NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $92 to $89.

Benzinga · 11/12/2019 16:46

Bank of America reiterates NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $92 to $89.